Category Archives: International PR

ExoCoBio obtained 2 GMP Licenses for Exosome Biopharmaceuticals from Korea MFDS and for Hyaluronic Acid (HA) Dermal Fillers from Brazil ANVISA · ExoGMP™ is the world’s largest exosome manufacturing facility in Osong, South Korea. · Cellosome™ HA fillers are expected to be approved in 2023. · ExoCoBio has all 3 types of GMP clearance for […]

This Summit, co-hosted with BENEV company of the US and LG Chem of Korea, will be the world’s largest event in the exosome industry, and attended by about 150 people including 100 doctors from 10 countries, professors, buyers and top experts such as Dr. Diane Duncan, Dr. Victor Ross, Dr. Randy Miller in the global […]

ExoCoBio Inc. has announced the initiation of its “Project EGMP”, starting with the construction of the world’s first exosome-based drug manufacturing & R&D facility (EGMP facility) in Osong, Chungcheongbuk-do, South Korea. Osong was created for a bio-cluster to attract biotechnology businesses with government agencies like Korea FDA. ExoCoBio will invest approximately $20M to build the […]

– The world’s first exosome-based regenerative aesthetics for scalp & hair SEOUL, South Korea, April 12, 2022 /PRNewswire/ — ExoCoBio Inc., one of the top 4 global players in the stem cell exosome industry, announced that it launched the premium hair solution, ASCE+™ HRLV, for the scalp rejuvenation and hair loss market. (image) Dr. Iñigo […]

Exosomes are nano-sized vesicles ranging from 30-200nm that are present in eukaryotic fluids and facilitate a diverse range of cellular functions. They transfer DNA, RNA, and proteins to other cells, thereby altering the function of the targeted cells. Because of their far ranging potential, exosomes can be commercialized as therapeutic agents, diagnostic tools, and cosmeceuticals. […]

* Its exosome-based regenerative aesthetics business is fast growing. * The IPO process will be initiated and stock trading is expected in 1Q 2021 on KOSDAQ. SEOUL, South Korea, Aug. 25, 2020 /PRNewswire/ — ExoCoBio Inc. announced that it recently raised $9.3 million in its series C and Pre-IPO funding. For this round, return VCs […]

To operate successfully within the exosome marketplace, it is vital to assess novel opportunities for product development. Currently, there are five market segments that compose the market for stem cell exosomes. These market segments include: Exosome therapeutics, diagnostic tools, research tools, cosmeceuticals, and manufacturing technologies. A cosmeceutical is a cosmetic product that has or is […]

Exosome-related technologies have been developing rapidly over the past few years, and substantial growth is expected for the market as they get integrated into the fields of liquid biopsy, precision medicine, and regenerative medicine. In particular, cancer-derived exosomes influence the invasive potential of cells by regulating angiogenesis, metastasis, and immunity, making them an extremely useful […]

ExoCoBio published Research Paper on ‘The World’s First Exosome-Based Treatment for Atopic Dermatitis’ ExoCoBio Inc., based in South Korea, published a scientific paper on that stem cell-derived exosomes dramatically relieves atopic dermatitis and inhibits a variety of inflammatory targets in the journal of Stem Cell Research and Therapy. According to the paper, the symptoms of […]

Exosome Start-up ExoCoBio Inc. raises $26.7M in Series B Funding ExoCoBio is the 4th largest funded exosome startup in the world ExoCoBio is using the funding to advance its exosome pharmaceutical R&D and cosmeceutical business. SEOUL, South Korea, Sept. 12, 2018 — ExoCoBio Inc. announced that it recently raised about $27 million in its series […]